| Authors: |
Talpin A; Enterome, Paris, Île-de-France, France., Maia A; Institute for Immunology and Cluster of Excellence iFIT (EXC2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard-Karls-University Tübingen, Tübingen, Germany., Carpier JM; Enterome, Paris, Île-de-France, France., Kulakowski G; Enterome, Paris, Île-de-France, France., Aubergeon L; Enterome, Paris, Île-de-France, France., Kervevan J; Enterome, Paris, Île-de-France, France., Gaal C; Enterome, Paris, Île-de-France, France., Strozzi F; Enterome, Paris, Île-de-France, France., Billerey C; Enterome, Paris, Île-de-France, France., Amable L; Enterome, Paris, Île-de-France, France., Mersceman T; Enterome, Paris, Île-de-France, France., Garnier A; Enterome, Paris, Île-de-France, France., Oliveira C; Enterome, Paris, Île-de-France, France., Calderon C; Enterome, Paris, Île-de-France, France., Bachrouche D; Enterome, Paris, Île-de-France, France., Ventujol C; Enterome, Paris, Île-de-France, France., Bernard L; Enterome, Paris, Île-de-France, France., Manteau A; Enterome, Paris, Île-de-France, France., Martinez J; Enterome, Paris, Île-de-France, France., Bonnet M; Enterome, Paris, Île-de-France, France., Noguerol J; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France., Laviolette K; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France., Boullerot L; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France., Malfroy M; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France., Chevalier G; Enterome, Paris, Île-de-France, France., Adotevi O; Université de Franche-Comté, EFS, INSERM, UMR 1098 RIGHT, F-25000 Besançon, France., Joffre O; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291 - CNRS UMR5051 - University Toulouse III, Toulouse, France., Idbaih A; Sorbonne Université, AP-HP, ICM, Hôpital Universitaire La Pitié-Salpêtrière, Paris, France., Vieito M; Hospital Universitari Vall d'Hebron, Barcelona, Catalunya, Spain., Ghiringhelli F; UMR 1231, Centre Georges-Francois Leclerc, Dijon, Bourgogne-Franche-Comté, France., Stradella A; Institut Catala D'Oncologia - Hospital Duran i Reynals, Barcelona, Spain., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Stuttgart, Germany., Burger MC; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany., Mildenberger I; Universitat Heidelberg Medizinische Fakultat Mannheim, Mannheim, Baden-Württemberg, Germany., Herrlinger U; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology, University Hospital Bonn, Bonn, Nordrhein-Westfalen, Germany., Reardon DA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wick W; Universitätsklinikum Heidelberg and German Cancer Research Center, Heidelberg, Baden-Württemberg, Germany., Gouttefangeas C; Institute for Immunology and Cluster of Excellence iFIT (EXC2180), Image-Guided and Functionally Instructed Tumor Therapies, Eberhard-Karls-University Tübingen, Tübingen, Germany., Bonny C; Enterome, Paris, Île-de-France, France., Chene L; Enterome, Paris, Île-de-France, France., Gamelas Magalhaes J; Enterome, Paris, Île-de-France, France jmagalhaes@enterome.com. |
